Trial Profile
Deucravacitinib (BMS-986165) in the Treatment of Lichen Planopilaris
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 20 Nov 2023
Price :
$35
*
At a glance
- Drugs Deucravacitinib (Primary)
- Indications Lichen planus
- Focus Therapeutic Use
- 13 Nov 2023 Status changed from not yet recruiting to recruiting.
- 16 Oct 2023 Status changed from planning to not yet recruiting.
- 25 Jan 2017 New trial record